Detalles de la búsqueda
1.
The effect of tumor laterality on survival for non-small cell lung cancer patients treated with radiotherapy.
Acta Oncol
; 58(10): 1393-1398, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31271075
2.
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial.
Front Immunol
; 14: 1117466, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36911725
3.
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV.
Front Oncol
; 12: 1023015, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36483037
4.
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment.
Oncoimmunology
; 11(1): 2026020, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35111385
5.
Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa Study.
Cancers (Basel)
; 13(4)2021 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33671555
6.
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms.
Front Oncol
; 11: 637420, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33718228
7.
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma.
Oncoimmunology
; 10(1): 1975889, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-38283034
8.
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial.
Front Immunol
; 11: 595035, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33240282
9.
Cancer immune therapy for lymphoid malignancies: recent advances.
Semin Immunopathol
; 41(1): 111-124, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30006739
10.
[Cancer immune therapy for the treatment of haematological malignancies].
Ugeskr Laeger
; 181(10)2019 Mar 04.
Artículo
en Da
| MEDLINE | ID: mdl-30869069
11.
[Therapeutic cancer vaccination for treatment of haematological cancers].
Ugeskr Laeger
; 181(20A)2019 Oct 14.
Artículo
en Da
| MEDLINE | ID: mdl-31610839
12.
Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies.
Front Immunol
; 9: 2264, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30327655
13.
Frequent adaptive immune responses against arginase-1.
Oncoimmunology
; 7(3): e1404215, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29399404
14.
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial.
Stem Cell Investig
; 3: 95, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28078275
Resultados
1 -
14
de 14
1
Próxima >
>>